US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

171.50

+1.610.95%

Volume:576.73K

Turnover:99.56M

Market Cap:544.42M

PE:- -

High:177.91

Open:170.28

Low:168.40

Close:169.89

52wk High:198.18

52wk Low:32.55

Shares:3.17M

Float Shares:3.17M

Volume Ratio:0.68

T/O Rate:18.17%

Dividend:1.34

Dividend Rate:0.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Jefferies Remains a Buy on SpyGlass Pharma (SGP)

uniQure Shares Surge 26% On US FDA Shakeup Even As Momentum Tumbles: Will New Leadership Greenlight Huntington's Therapy?

Benzinga_recent_news

TransMedics: Early 2026 DCD and Liver Transplant Momentum Supports Upside and Maintained Buy Rating

China Tian Yuan Healthcare Schedules Board Meeting to Approve 2025 Results and Consider Dividend

Changchun High-Tech Subsidiary's GenSci128 Tablet Receives FDA Orphan Drug Status for Pancreatic Cancer

Analysts’ Top Healthcare Picks: Keros Therapeutics (KROS), HeartFlow, Inc. (HTFL)

Bernie Sanders Says 'What About Humans?' As Luxury Pet Health Care Booms While 85 Million Americans Remain Uninsured

Benzinga_recent_news

Seikagaku Resubmits U.S. Application for Disc Herniation Drug After Addressing FDA Concerns

MT Newswires Live

Table: CHC Healthcare Group FY Net Profit NT$186.3M Vs NT$168.4M

BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day

EPF fine-tunes but maintains major stake in IHH Healthcare

Huahai Pharmaceutical's Generic Drug Gabapentin Capsules Approved by US FDA

Hansa Biopharma to Spotlight Immunomodulatory Platform at DNB Carnegie Healthcare Conference

Executive Program Spotlight: Global Commercial Health Insurance Innovation Bootcamp

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Jazz Pharmaceuticals (JAZZ) and Talkspace (TALK)

Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Jazz Pharmaceuticals (JAZZ)

Cross Country Healthcare’s Deal Risks: Terminated Aya Merger Highlights Acquisition Pitfalls and Financial Exposure

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neurosense Therapeutics Ltd. (NRSN) and Novo Nordisk (NVO)

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and HCA Healthcare (HCA)

ASX Midday Sector Update: Health Care Stocks Rise, Energy Struggles

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":171.5,"timestamp":1773172800000,"preClose":169.89,"halted":0,"volume":576725,"delay":0,"changeRate":0.009476720230737617,"floatShares":3174486,"shares":3174486,"eps":0,"marketStatus":"Pre-Mkt","change":1.61,"latestTime":"03-11 05:31:54 EDT","open":170.28,"high":177.91,"low":168.4,"amount":99555099.984,"amplitude":0.055977,"askPrice":171.5,"askSize":100,"bidPrice":168.72,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773235800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":171.5,"sharesOutstanding":3074486,"nav":169.927,"aum":539431184.54,"dividendRate":0.0078,"bidAskSpread":0.001771,"postHourTrading":{"tag":"盘后","latestPrice":171.5,"preClose":171.5,"latestTime":"19:56 EDT","volume":5026,"amount":860673.7631,"timestamp":1773186982574,"change":0,"changeRate":0,"amplitude":0.00758},"volumeRatio":0.6764409140010272,"impliedVol":0.9938,"impliedVolPercentile":0.792},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3174486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6764409140010272,"shares":3174486,"dividePrice":1.3377,"high":177.91,"amplitude":0.055977,"preClose":169.89,"low":168.4,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":171.5,"committee":-0.980198,"eps":0,"divideRate":0.0078,"volume":576725,"delay":0,"ttmEps":0,"open":170.28,"prevYearClose":159.39,"prevWeekClose":158.47,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":156.86,"twentyDayClose":169.18,"sixtyDayClose":160.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618999953","title":"Jefferies Remains a Buy on SpyGlass Pharma (SGP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618999953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618999953?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:55","pubTimestamp":1773147340,"startTime":"0","endTime":"0","summary":"Jefferies analyst Dennis Ding reiterated a Buy rating on SpyGlass Pharma today and set a price target of $62.00. Ding covers the Healthcare sector,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-spyglass-pharma-sgp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-spyglass-pharma-sgp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LABU","BK4585","XLV","SGP","BK4588","XBI","BK4581"],"gpt_icon":0},{"id":"2618930748","title":"uniQure Shares Surge 26% On US FDA Shakeup Even As Momentum Tumbles: Will New Leadership Greenlight Huntington's Therapy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618930748","media":"Benzinga_recent_news","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618930748?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:17","pubTimestamp":1773145020,"startTime":"0","endTime":"0","summary":"uniQure (QURE) stock surges 26% as FDA's Prasad exits. See why Benzinga Edge momentum fell to 28.01 despite the rally.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/10/Silver-Spring--Md--Usa---June-25--2022-T.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/10/Silver-Spring--Md--Usa---June-25--2022-T.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/03/51154335/uniqure-shares-surge-26-on-us-fda-shakeup-even-as-momentum-tumbles-will-new-leadership-greenlight-huntingtons-therapy","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/03/51154335/uniqure-shares-surge-26-on-us-fda-shakeup-even-as-momentum-tumbles-will-new-leadership-greenlight-huntingtons-therapy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4588","BK4585","LABU"],"gpt_icon":0},{"id":"2618930823","title":"TransMedics: Early 2026 DCD and Liver Transplant Momentum Supports Upside and Maintained Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618930823","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618930823?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:55","pubTimestamp":1773143742,"startTime":"0","endTime":"0","summary":"TransMedics Group, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William Plovanic from Canaccord Genuity...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/transmedics-early-2026-dcd-and-liver-transplant-momentum-supports-upside-and-maintained-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/transmedics-early-2026-dcd-and-liver-transplant-momentum-supports-upside-and-maintained-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","XLV","BK4588","LABU","BK4585"],"gpt_icon":0},{"id":"2618937351","title":"China Tian Yuan Healthcare Schedules Board Meeting to Approve 2025 Results and Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2618937351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618937351?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:39","pubTimestamp":1773142770,"startTime":"0","endTime":"0","summary":"China Tian Yuan Healthcare Group Limited ( ($HK:0557) ) has issued an announcement. China Tian Yuan Healthcare Group Limited has scheduled a board ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-tian-yuan-healthcare-schedules-board-meeting-to-approve-2025-results-and-consider-dividend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-tian-yuan-healthcare-schedules-board-meeting-to-approve-2025-results-and-consider-dividend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0128526141.USD","LABU","LU0029874061.USD","BK4581","BK4588","HCSG","BK4585","BK4137","XBI"],"gpt_icon":0},{"id":"1136852852","title":"Changchun High-Tech Subsidiary's GenSci128 Tablet Receives FDA Orphan Drug Status for Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1136852852","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136852852?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:49","pubTimestamp":1773139788,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. has announced that its subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd., recently received notification from the U.S. Food and Drug Administration...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","000661","BK0075","BK0057","BK0188","BK4588","BK4585","BK0028","BK0046","BK0239"],"gpt_icon":0},{"id":"2618931934","title":"Analysts’ Top Healthcare Picks: Keros Therapeutics (KROS), HeartFlow, Inc. (HTFL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618931934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618931934?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:41","pubTimestamp":1773139278,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Keros Therapeutics (KROS – Research Report), HeartFl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-keros-therapeutics-kros-heartflow-inc-htfl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-keros-therapeutics-kros-heartflow-inc-htfl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","BK4167","HCSG","BK4585","LU0029874061.USD","KROS","BK4581","LABU","LU0128526141.USD","XBI","HTFL","XLV","BK4139"],"gpt_icon":0},{"id":"2618931553","title":"Bernie Sanders Says 'What About Humans?' As Luxury Pet Health Care Booms While 85 Million Americans Remain Uninsured","url":"https://stock-news.laohu8.com/highlight/detail?id=2618931553","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618931553?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:30","pubTimestamp":1773138600,"startTime":"0","endTime":"0","summary":"Sen. Bernie Sanders highlights health care gap while pets receive luxury care. Millions of uninsured Americans. Calls for Medicare for All.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/10/Des-Moines--Iowa---September-21--2019-Be.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/10/Des-Moines--Iowa---September-21--2019-Be.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/politics/26/03/51151220/bernie-sanders-says-what-about-humans-as-luxury-pet-health-care-booms-while-85-million-americans-remain-uninsured","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/politics/26/03/51151220/bernie-sanders-says-what-about-humans-as-luxury-pet-health-care-booms-while-85-million-americans-remain-uninsured","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4581","BK4585","BK4588","LABU","XBI","XLV"],"gpt_icon":0},{"id":"2618939123","title":"Seikagaku Resubmits U.S. Application for Disc Herniation Drug After Addressing FDA Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2618939123","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618939123?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:23","pubTimestamp":1773138223,"startTime":"0","endTime":"0","summary":"Seikagaku  resubmitted its biologics license application to the U.S. FDA for SI-6603 , a potential treatment for lumbar disc herniation, according to its Tokyo bourse filing on Tuesday.The resubmission follows a complete response letter  received in March 2025, which raised no concerns about the drug's clinical efficacy or safety but cited issues related to the manufacturing facility and quality control.The CRL is an FDA notification that an application will not be approved in its current state after review.Seikagaku has since addressed these observations and is working with licensing partner Ferring Pharmaceuticals to pursue approval and offer a new non-surgical option for reducing leg pain associated with the condition.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0390134368.USD","BK4585","CRL.AU","LABU","LU0757428866.USD","LU1815336091.USD","LU0029874061.USD","LU0128526141.USD","CRL","BK4588","BK7095","BK4530","IE00BFMHRM44.USD","BK4121"],"gpt_icon":0},{"id":"2618391279","title":"Table: CHC Healthcare Group FY Net Profit NT$186.3M Vs NT$168.4M","url":"https://stock-news.laohu8.com/highlight/detail?id=2618391279","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618391279?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:22","pubTimestamp":1773138120,"startTime":"0","endTime":"0","summary":"Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4137","XLV","LABU","LU0128526141.USD","HCSG","XBI","BK4585","LU0029874061.USD","BK4581"],"gpt_icon":0},{"id":"2618362789","title":"BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2618362789","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618362789?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:00","pubTimestamp":1773136800,"startTime":"0","endTime":"0","summary":"BPL003 holds Breakthrough Therapy Designation and is supported by positive Phase 2b results in treatment-resistant depressionCash runway reaffirmed through the planned early-2029 topline readouts from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/10/3252558/0/en/BPL-003-Phase-3-Program-Initiation-on-Track-for-Q2-2026-Following-Successful-FDA-End-of-Phase-2-Meeting-AtaiBeckley-Highlights-Key-Pipeline-Milestones-at-2026-Investor-Day.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4539","BK4585","R","ATAI","BK4007","BK4588","BK4232","BK4022"],"gpt_icon":0},{"id":"2618230936","title":"EPF fine-tunes but maintains major stake in IHH Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2618230936","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618230936?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:44","pubTimestamp":1773135853,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) has provided an update. Malaysia’s Employees Provident Fund Board (EPF), a substantial shareholder in IHH Healthcar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-fine-tunes-but-maintains-major-stake-in-ihh-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-fine-tunes-but-maintains-major-stake-in-ihh-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4137","XLV","LU0128526141.USD","BK4585","LU0029874061.USD","XBI","BK4588","LABU","HCSG"],"gpt_icon":0},{"id":"1153571945","title":"Huahai Pharmaceutical's Generic Drug Gabapentin Capsules Approved by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1153571945","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153571945?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:34","pubTimestamp":1773135257,"startTime":"0","endTime":"0","summary":"Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SH) announced that its subsidiary, Prinston Pharmaceutical Co., Ltd., has received approval from the U.S. Food and Drug Administration (FDA) for its...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0201","BK0185","BK4585","LABU","BK0012","BK0028","BK0239","BK4588","BK0188","600521","BK0070"],"gpt_icon":0},{"id":"2618935784","title":"Hansa Biopharma to Spotlight Immunomodulatory Platform at DNB Carnegie Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2618935784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618935784?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:33","pubTimestamp":1773135218,"startTime":"0","endTime":"0","summary":"The latest update is out from Hansa Biopharma AB ( ($SE:HNSA) ). Hansa Biopharma AB, a Swedish commercial-stage biopharmaceutical company specializ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hansa-biopharma-to-spotlight-immunomodulatory-platform-at-dnb-carnegie-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hansa-biopharma-to-spotlight-immunomodulatory-platform-at-dnb-carnegie-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0345776255.USD","LU2125910500.SGD","LU0516422440.USD","SG9999013486.USD","BK4220","SG9999014484.SGD","LU1861220207.SGD","LU0210637038.USD","LU0516422952.EUR","LU0345775950.USD","SG9999002620.SGD","IE0031814969.USD","BK4535","LU0251143029.SGD","SG9999002414.USD","LU2045819591.USD","SG9999002679.SGD","LU0532188223.SGD","LU0979878070.USD","LU0572939691.SGD","LU0264606111.USD","BK4554","BK4551","LU0499858438.USD","LU2177674079.SGD","LU1770036033.HKD","LU0441851309.USD","LU2065171311.SGD","LU0175139822.USD","LU0289960550.SGD","SG9999013478.USD","LU1048588211.SGD","LU0516422366.SGD","LU2152927971.USD","LU0572940350.SGD","LU0048573645.USD","BK4123","SG9999006266.SGD","LU1839390173.USD","BK4548","SG9999002604.SGD","LU0029874061.USD","LU2238330802.EUR","IE0001KFT4U8.USD","BK4581","LU0499858602.USD","LU0516423174.USD","LU0589944569.HKD","LU2065169927.USD","BK4566","BK4585","SG9999014492.USD","LU0737861269.HKD","LU1861217088.USD","LU0823039010.USD","SG9999002406.SGD","LU0128526141.USD","LU2065170008.USD","LU2543165471.USD","LU1242518931.SGD","BK4085","HNSBF","BK4503","SG9999005177.SGD","LU0348788117.USD","LU2125910849.SGD","BK4588","LU0823038988.USD","LU2008162690.USD","IE0034224299.USD","BK4137","IE00BD6J9T35.USD","SG9999001135.SGD","SG9999013460.SGD","LU2065171402.SGD","LU2360107671.USD","LU0261945553.USD","LU0072462343.USD","SG9999004360.SGD","SGXZ58947870.SGD","XBI","LU0516423091.SGD","LU1242518857.USD","LABU"],"gpt_icon":0},{"id":"1167853425","title":"Executive Program Spotlight: Global Commercial Health Insurance Innovation Bootcamp","url":"https://stock-news.laohu8.com/highlight/detail?id=1167853425","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167853425?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:22","pubTimestamp":1773134556,"startTime":"0","endTime":"0","summary":"The Chinese healthcare industry is undergoing a significant transformation. With the deepening of medical insurance payment reforms, the accelerated development of commercial health insurance, and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","BK4581","BK4588","XBI","LABU"],"gpt_icon":0},{"id":"2618337199","title":"Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Jazz Pharmaceuticals (JAZZ) and Talkspace (TALK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618337199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618337199?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:20","pubTimestamp":1773134424,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zevra Therapeutics (ZVRA – Research Report), Jazz Pharmaceuticals...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zevra-therapeutics-zvra-jazz-pharmaceuticals-jazz-and-talkspace-talk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zevra-therapeutics-zvra-jazz-pharmaceuticals-jazz-and-talkspace-talk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","TALK","BK4585","IE00BN0W2T93.GBP","LU0823416689.USD","BK4588","IE00BN0W2V16.EUR","BK4532","IE00BN0W2W23.USD","JAZZ","BK4581","LU0029874061.USD","LU0889565916.HKD","XLV","LU0320765992.SGD","BK4137","BK4533","HCSG","LU0109394709.USD","LU0154245673.USD","ZVRA","BK4007","LU0154245756.USD","BK4196","XBI","LABU"],"gpt_icon":0},{"id":"2618803359","title":"Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Jazz Pharmaceuticals (JAZZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618803359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618803359?lang=en_us&edition=fundamental","pubTime":"2026-03-10 16:10","pubTimestamp":1773130226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rapport Therapeutics, Inc. (RAPP – Research Report),...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-rapport-therapeutics-inc-rapp-jazz-pharmaceuticals-jazz-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-rapport-therapeutics-inc-rapp-jazz-pharmaceuticals-jazz-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","RAPP","XBI","IE00BN0W2T93.GBP","BK4588","JAZZ","LU0889565916.HKD","BLSX","BK4533","BK4581","LU0128526141.USD","BK4585","IE00BN0W2V16.EUR","LU0109394709.USD","LU0823416689.USD","LABU","BK4137","LU0154245673.USD","BLSG","IE00BN0W2W23.USD","BK4112","LU0154245756.USD","LU0029874061.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2618986521","title":"Cross Country Healthcare’s Deal Risks: Terminated Aya Merger Highlights Acquisition Pitfalls and Financial Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2618986521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618986521?lang=en_us&edition=fundamental","pubTime":"2026-03-10 14:00","pubTimestamp":1773122436,"startTime":"0","endTime":"0","summary":"Cross Country Healthcare (CCRN) has disclosed a new risk, in the Corporate Activity and Growth category. Cross Country Healthcare continually evalu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cross-country-healthcares-deal-risks-terminated-aya-merger-highlights-acquisition-pitfalls-and-financial-exposure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cross-country-healthcares-deal-risks-terminated-aya-merger-highlights-acquisition-pitfalls-and-financial-exposure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4196","LABU","CCRN","XBI","BK4588","BK4585","XLV"],"gpt_icon":0},{"id":"2618988022","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neurosense Therapeutics Ltd. (NRSN) and Novo Nordisk (NVO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618988022","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618988022?lang=en_us&edition=fundamental","pubTime":"2026-03-10 12:30","pubTimestamp":1773117012,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report) and Novo No...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neurosense-therapeutics-ltd-nrsn-and-novo-nordisk-nvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neurosense-therapeutics-ltd-nrsn-and-novo-nordisk-nvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","IE00BZ1G4Q59.USD","BK4599","LU0029874061.USD","LU0128526141.USD","NVOX","NVOH","LABU","BK4588","BK4137","BK4139","BK4581","LU0154236417.USD","IE00BKVL7J92.USD","BK4007","LU1093756168.USD","XBI","NVO","LU1093756325.SGD","NRSN","BK4585"],"gpt_icon":0},{"id":"2618867607","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and HCA Healthcare (HCA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618867607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618867607?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:50","pubTimestamp":1773111011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX – Research Report) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","XBI","XLV","IE00B775SV38.USD","LU1778281490.HKD","LU1035775433.USD","BK4533","LU0109394709.USD","LU1674673428.USD","IE00BJT1NW94.SGD","HCA","SG9999014021.USD","LU1150488135.SGD","LU0757428866.USD","LU0882574055.USD","LU0432979614.USD","IE0002270589.USD","BK4585","LU1267930573.SGD","IE00B19Z3B42.SGD","LU1119994496.HKD","LU0130102774.USD","LU1069344957.HKD","BK4023","LU0310799852.SGD","SG9999013999.USD","LU2237438978.USD","IE00B2B36J28.USD","LU1559883803.SGD","LU2244417387.USD","IE00B4R5TH58.HKD","LU2362541513.USD","LABU","BK4532","LU0203345920.USD","LU0029864427.USD","LU0417517546.SGD","LU1150488218.USD","BK4504","SG9999014013.SGD","BK4588","LU1430594728.SGD","LU0889565916.HKD","LU0310800379.SGD","LU0068578508.USD","IE00B894F039.SGD","LU0433182093.SGD","VRTX","LU0058720904.USD"],"gpt_icon":0},{"id":"2618960455","title":"ASX Midday Sector Update: Health Care Stocks Rise, Energy Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2618960455","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618960455?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:08","pubTimestamp":1773108507,"startTime":"0","endTime":"0","summary":"Health care stocks advanced 2% at midday Tuesday.CSL  shares rose more than 2% in recent trade after the biotechnology company disclosed the $1.5 billion expansion of its Illinois plasma therapy manufacturing facility on Monday.Meanwhile, the energy sector struggled, shedding 4% amid geopolitical tensions in the Middle East.Woodside Energy Group  shares fell past 5% in recent trade, while Santos  shares fell 4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7142","WDS.AU","BK4588","BK7507","BK4581","BK7067","XBI","BK7508","BK7501","XLV","CSL.AU","LABU","BK4585","BK7511","STO.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":23,"pageCount":3,"totalSize":450,"code":"91000000","status":"200"}]}}